Outlook Therapeutics, Inc. (OTLK)

0.4397 +0.03 (+6.98%) USD  |  NASDAQ  |  Feb 25, 16:00
0.4397 0.00 (0.00%) After-Hours: 18:22
More

Outlook Therapeutics Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for OTLK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Neogen Corp. Upgrade
CorMedix, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade